Compare SEB & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SEB | BLCO |
|---|---|---|
| Founded | 1918 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Ophthalmic Goods |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.0B | 5.4B |
| IPO Year | 1994 | 2022 |
| Metric | SEB | BLCO |
|---|---|---|
| Price | $4,555.57 | $16.27 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 11 |
| Target Price | N/A | ★ $18.45 |
| AVG Volume (30 Days) | 5.1K | ★ 340.4K |
| Earning Date | 05-12-2026 | 04-29-2026 |
| Dividend Yield | ★ 0.17% | N/A |
| EPS Growth | ★ 467.71 | N/A |
| EPS | ★ 124.24 | N/A |
| Revenue | ★ $5,809,000,000.00 | $5,101,000,000.00 |
| Revenue This Year | N/A | $8.65 |
| Revenue Next Year | N/A | $5.59 |
| P/E Ratio | $37.17 | ★ N/A |
| Revenue Growth | ★ 7.99 | 6.47 |
| 52 Week Low | $2,990.00 | $13.09 |
| 52 Week High | $5,989.37 | $18.92 |
| Indicator | SEB | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 42.10 | 51.28 |
| Support Level | $4,265.35 | $15.36 |
| Resistance Level | $4,800.00 | $16.54 |
| Average True Range (ATR) | 158.52 | 0.48 |
| MACD | 24.19 | -0.03 |
| Stochastic Oscillator | 59.80 | 22.58 |
Seaboard Corp is a diversified group of companies that operate in agricultural, energy, and ocean transport businesses. The company is engaged in hog production, biofuel production, and pork processing in the United States; commodity trading and grain processing in Africa and South America; cargo shipping services in the U.S., Caribbean and Central and South America; sugar and alcohol production in Argentina; and electric power generation in the Dominican Republic. It also has an equity method investment in Butterball, LLC, a producer and processor of turkey products. The group's operating segments are; pork, commodity trading and milling, marine, liquid fuels, power, turkey, and others. It operates in 45 countries, with a concentration in the Caribbean, Central and South American region.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.